October 22, 2020

GenSight Biologics S A : successfully raises €25 million in an oversubscribed private placement with US and European institutional investors

Paris, France, October 22 2020, 6.30 am CEST The following information is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or ph...
Read more
October 21, 2020

InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing

Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2...
Read more
October 19, 2020

Updated CERAMENT BONE VOID FILLER (BVF) instructions for use for the US market

Lund, Sweden, 15:00 CET, 19 October 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announces that the company, through a 510 (...
Read more
October 19, 2020

Oncopeptides has submitted an Investigational New Drug application to FDA for the second drug candidate from the PDC platform

STOCKHOLM — October 19, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has submitted an Investigational New Drug (IND) applicatio...
Read more
October 15, 2020

GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update

Paris, France, October 15, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commerc...
Read more
October 15, 2020

Orexo and Lyfebulb Announce the Winner of the 2020 Innovation Challenge in Substance Use Disorders

UPPSALA, SWEDEN, AND NEW YORK, NY, USA, October 15th, 2020: Orexo, a Swedish pharmaceutical company focused on improved pharmaceuticals and digital therapies, and Lyfebulb, a pati...
Read more
October 14, 2020

Aprea Therapeutics Launches Disease Awareness Website for Healthcare Professionals, p53reactivation.com

BOSTON, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeut...
Read more
October 14, 2020

GenSight Biologics Appoints Elsy Boglioli to its Board of Directors

Paris, France, October 14, 2020, 7:30 am CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commerc...
Read more
October 14, 2020

Targovax ASA – successfully completed private placement

    For more information, please see Targovax ASA – successfully completed private placement             ...
Read more
October 14, 2020

Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN FRANCISCO--(BUSINESS WIRE)--Oct. 14, 2020-- Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare ...
Read more